Back to Search
Start Over
Real-World Data on the Use of Glecaprevir/Pibrentasvir in the Treatment of Hepatitis C: Is Shorter Treatment Possible?
- Source :
- Viral Hepatitis Journal / Viral Hepatit Dergisi; Aug2024, Vol. 30 Issue 2, p36-40, 5p
- Publication Year :
- 2024
-
Abstract
- <i>Copyright of Viral Hepatitis Journal / Viral Hepatit Dergisi is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
- Subjects :
- RNA analysis
THERAPEUTIC use of protease inhibitors
COMBINATION drug therapy
CROSS-sectional method
SUBSTANCE abuse
VIRAL load
RETROSPECTIVE studies
TREATMENT effectiveness
DESCRIPTIVE statistics
TREATMENT duration
ANTIVIRAL agents
DRUG efficacy
CHRONIC hepatitis C
GENOTYPES
PATIENT aftercare
DRUG tolerance
DISEASE risk factors
DISEASE complications
Subjects
Details
- Language :
- English
- ISSN :
- 13079441
- Volume :
- 30
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Viral Hepatitis Journal / Viral Hepatit Dergisi
- Publication Type :
- Academic Journal
- Accession number :
- 179430949
- Full Text :
- https://doi.org/10.4274/vhd.galenos.2024.2024-2-1